PolyPid (PYPD) to Release Earnings on Wednesday

PolyPid (NASDAQ:PYPD) is projected to release its earnings data before the market opens on Wednesday, February 12th. Analysts expect PolyPid to post earnings of ($0.90) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

PolyPid Stock Performance

PYPD stock opened at $3.07 on Tuesday. PolyPid has a 1-year low of $2.37 and a 1-year high of $7.00. The firm has a fifty day moving average price of $3.03 and a two-hundred day moving average price of $3.33. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 1.17.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on PYPD shares. HC Wainwright dropped their price objective on shares of PolyPid from $14.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, December 26th. Craig Hallum started coverage on PolyPid in a research report on Monday, November 4th. They set a “buy” rating and a $10.00 price target on the stock. RODMAN&RENSHAW upgraded PolyPid to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Rodman & Renshaw started coverage on shares of PolyPid in a research report on Tuesday, January 28th. They issued a “buy” rating and a $13.00 target price for the company.

About PolyPid

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.